These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 3567519)
1. Predictive power of progesterone receptor status in early breast carcinoma. Sutton R; Campbell M; Cooke T; Nicholson R; Griffiths K; Taylor I Br J Surg; 1987 Mar; 74(3):223-6. PubMed ID: 3567519 [TBL] [Abstract][Full Text] [Related]
2. Steroid receptors and prognosis in operable (stage I and II) breast cancer. Stewart JF; Rubens RD; Millis RR; King RJ; Hayward JL Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1381-7. PubMed ID: 6315442 [TBL] [Abstract][Full Text] [Related]
3. Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifen. Bonomi P; Gale M; Von Roenn J; Anderson K; Johnson P; Wolter J; Economou S Semin Oncol; 1988 Apr; 15(2 Suppl 1):26-33. PubMed ID: 3368797 [TBL] [Abstract][Full Text] [Related]
4. [Significance of hormone receptors of breast cancer cells for the duration of a disease-free interval]. Zielinski CC; Kuzmits R; Kubista E; Salzer H; Staffen A; Aiginger P; Spona J Wien Klin Wochenschr; 1985 May; 97(11):493-7. PubMed ID: 4013343 [TBL] [Abstract][Full Text] [Related]
5. Estrogen and progesterone receptors as prognostic factors in breast cancer. Brdar B; Graf D; Padovan R; Nola P; Rudan N; Petrinec Z; Sarcević B; Belicza M Tumori; 1988 Feb; 74(1):45-52. PubMed ID: 3354064 [TBL] [Abstract][Full Text] [Related]
6. Steroid hormone receptors and prognosis in breast cancer. Daxenbichler G; Forsthuber EP; Marth C; Kemmler G; Wiegele J; Margreiter R; Müller L; Hausmaninger H; Manfreda D; Dapunt O Breast Cancer Res Treat; 1988 Dec; 12(3):267-73. PubMed ID: 3228589 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of oestrogen and progestogen receptor activities in breast cancer. Hawkins RA; White G; Bundred NJ; Dixon JM; Miller WR; Stewart HJ; Forrest AP Br J Surg; 1987 Nov; 74(11):1009-13. PubMed ID: 3690224 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of progesterone receptors alone or in association with estrogen receptors in human breast cancer. Di Fronzo G; Cappelletti V; Coradini D; Ronchi E; Scavone G Tumori; 1984 Apr; 70(2):159-64. PubMed ID: 6730014 [TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Overgaard J; J Clin Oncol; 2008 Mar; 26(9):1419-26. PubMed ID: 18285604 [TBL] [Abstract][Full Text] [Related]
10. Quantitative oestrogen and progesterone receptor values in primary breast cancer and predictability of response to endocrine therapy. Fernandez MD; Alaghband-Zadeh J; Burn JI Clin Oncol; 1983 Sep; 9(3):245-50. PubMed ID: 6616999 [TBL] [Abstract][Full Text] [Related]
11. Progesterone and estrogen receptors as prognostic variables in breast cancer. Mason BH; Holdaway IM; Mullins PR; Yee LH; Kay RG Cancer Res; 1983 Jun; 43(6):2985-90. PubMed ID: 6850609 [TBL] [Abstract][Full Text] [Related]
12. The oestrogen-progesterone receptor ratio: an indicator of breast cancer evolution. Cherubini M; Baxa P; Guarino G Chir Ital; 2002; 54(4):423-8. PubMed ID: 12239750 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols. Foekens JA; Portengen H; van Putten WL; Peters HA; Krijnen HL; Alexieva-Figusch J; Klijn JG Cancer Res; 1989 Nov; 49(21):5823-8. PubMed ID: 2676151 [TBL] [Abstract][Full Text] [Related]
14. [Receptor status and ovarian function in carcinoma of the breast]. Giuffrida D; La Porta GA; Sicurella C; La Rosa GL; Milazzo G; Foti E; Marchese V; Lanza C; Vigneri R; Belfiore A G Ital Oncol; 1989; 9(2-3):73-6. PubMed ID: 2767731 [TBL] [Abstract][Full Text] [Related]
15. Steroid-hormone receptors and survival after first relapse in breast cancer. Howell A; Barnes DM; Harland RN; Redford J; Bramwell VH; Wilkinson MJ; Swindell R; Crowther D; Sellwood RA Lancet; 1984 Mar; 1(8377):588-91. PubMed ID: 6142305 [TBL] [Abstract][Full Text] [Related]
16. Proliferative index of breast carcinoma by thymidine labeling: prognostic power independent of stage, estrogen and progesterone receptors. Meyer JS; Province M Breast Cancer Res Treat; 1988 Oct; 12(2):191-204. PubMed ID: 3242648 [TBL] [Abstract][Full Text] [Related]
17. Hormone receptors and disease-free survival in breast cancer: impact of increasing threshold levels. Di Fronzo G; Coradini D; Cappelletti V; Miodini P; Granata G; Schwartz M; Panko WB Anticancer Res; 1990; 10(6):1699-705. PubMed ID: 2285244 [TBL] [Abstract][Full Text] [Related]
18. [The importance of steroid receptors for the prognosis and hormone treatment of breast cancer patients: a retrospective study in Southeastern Netherlands]. Voogd AC; Crommelin MA; Repelaer van Driel OJ; Tutein Nolthenius-Puylaert MC; Vreugdenhil G; Coebergh JW Ned Tijdschr Geneeskd; 1998 Aug; 142(31):1772-8. PubMed ID: 9856143 [TBL] [Abstract][Full Text] [Related]
19. Oestrogen and progesterone receptors and disease-free interval in primary breast cancer. Alanko A; Heinonen E; Scheinin TM; Tolppanen EM; Vihko R Br J Cancer; 1984 Nov; 50(5):667-72. PubMed ID: 6498064 [TBL] [Abstract][Full Text] [Related]
20. Prediction of relapse and survival in breast cancer patients by pS2 protein status. Foekens JA; Rio MC; Seguin P; van Putten WL; Fauque J; Nap M; Klijn JG; Chambon P Cancer Res; 1990 Jul; 50(13):3832-7. PubMed ID: 2354435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]